Clinical trials
Phase 1/2 Rhabdomyosarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| Eisai Inc. | 1 |
| Milton S. Hershey Medical Center | 1 |
| Novartis Pharmaceuticals | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 8 |
| Neuroblastoma | 6 |
| Osteosarcoma | 4 |
| Neuroectodermal Tumors, Primitive, Peripheral | 3 |
| Sarcoma, Ewing | 3 |
| Central Nervous System Neoplasms | 2 |
| Glioma | 2 |
| Hepatoblastoma | 2 |
| Medulloblastoma | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.